TTOPSTART BV -  

Ranking results:

Past rankings:

2020
Criterium:Position:
Overall Score:> 1000
Total Project Funding per Partner:> 1000
Total Number of Projects:> 1000
2019
Criterium:Position:
Overall Score:> 1000
Total Project Funding per Partner:> 1000
Total Number of Projects:> 1000
2018
Criterium:Position:
Overall Score:> 1000
Total Project Funding per Partner:> 1000
Total Number of Projects:> 1000
Networking Rank (Reputation):> 1000
2016
Criterium:Position:
Overall Score:> 1000
Networking Rank (Reputation):> 1000
2015
Criterium:Position:
Overall Score:> 1000
Networking Rank (Reputation):> 1000

Ranking timeline:

Project Participation Performance(2015-01-01 - 2022-12-31 ):

Total Project Funding:

Funding per Partner:

Projects:

Leadership:

Total number of projects: 16
As coordinator: 1
As participant: 15
Sole participant: 0
Coordinator / Participant Ratio: 0.07*

Summary:

Total project funding [€]:Projects [No]:
Year:coordinator*participant*per partner  as coordinatoras participant
2022 0 14.866.441 160.000 1
2021 0 53.214.762 692.561 3
2020 0 9.526.097 180.750 1
2019 0 34.244.029 467.130 3
2018 0 13.819.617 225.000 3
2017 1.999.624 9.860.059 271.105 1 2
2016 0 8.291.218 150.000 1
2015 0 5.834.340 125.000 1

Networking:

Partners:

Institution:Projects [No]:
EUROPEAN CANCER PATIENT COALITION7
BAYER5
BIOBANKS AND BIOMOLECULAR RESOURCES RESEARCH INFRASTRUCTURE CONSORTIUM4
JANSSEN PHARMACEUTICA NV4
PFIZER LIMITED4
UPPSALA UNIVERSITET4
ACADEMISCH ZIEKENHUIS GRONINGEN3
ERASMUS UNIVERSITAIR MEDISCH CENTRUM ROTTERDAM3
EUROPEAN ORGANISATION FOR RESEARCH AND TREATMENT OF CANCER AISBL3
F HOFFMANNLA ROCHE3
KATHOLIEKE UNIVERSITEIT LEUVEN3
NOVARTIS PHARMA3
QUEEN MARY AND WESTFIELD COLLEGE UNIVERSITY OF LONDON3
SANOFIAVENTIS3
UNIVERSITEIT MAASTRICHT3
UNIVERSITY COLLEGE LONDON3
ABBVIE INC2
ARTTIC INNOVATION2
ASSOCIATION EISBM2
BOEHRINGER INGELHEIM PHARMA GMBH &CO KG2
COVANCE LABORATORIES2
CSC TIETEEN TIETOTEKNIIKAN KESKUS OY2
EBERHARD KARLS UNIVERSITAET TUEBINGEN2
ELI LILLY AND COMPANY LIMITED2
EUROPEAN MOLECULAR BIOLOGY LABORATORY2
FRAUNHOFER GESELLSCHAFT ZUR FOERDERUNG DER ANGEWANDTEN FORSCHUNG E V2
FUNDACIO PRIVADA INSTITUT D'INVESTIGACIO ONCOLOGICA DE VALLHEBRON2
HELSINGIN JA UUDENMAAN SAIRAANHOITOPIIRIN KUNTAYHTYMAE2
INSTITUT NATIONAL DE LA SANTE ET DE LA RECHERCHE MEDICALE2
LINKOPINGS UNIVERSITET2
LUND UNIVERSITY2
MEDIZINISCHE UNIVERSITAT GRAZ2
NOVO NORDISK2
OWKIN FRANCE2
STICHTING EUROPEAN UROLOGICAL FOUNDATION2
STICHTING KATHOLIEKE UNIVERSITEIT2
STICHTING LYGATURE2
STICHTING VUMC2
TAKEDA DEVELOPMENT CENTRE EUROPE2
TAKEDA PHARMACEUTICALS INTERNATIONAL2
TARTU ULIKOOL2
TECHNISCHE UNIVERSITAET MUENCHEN2
THE CHANCELLOR MASTERS AND SCHOLARS OF THE UNIVERSITY OF OXFORD2
THE EUROPEAN INSTITUTE FOR INNOVATION THROUGH HEALTH DATA2
THE UNIVERSITY OF MANCHESTER2
UCB BIOPHARMA2
UNIVERSITA DEGLI STUDI DI TORINO2
UNIVERSITA VITASALUTE SAN RAFFAELE2
UNIVERSITAETSKLINIKUM HAMBURGEPPENDORF2
UNIVERSITAIR MEDISCH CENTRUM UTRECHT2
UNIVERSITE DE LIEGE2
UNIVERSITEIT TWENTE2
UNIVERSITY OF ABERDEEN2
UNIVERSITY OF CAMBRIDGE2
2M ENGINEERING LIMITED1
AARHUS KOMMUNEHOSPITAL AARHUS UNIVERSITY HOSPITAL1
AGENZIA REGIONALE DI SANITA1
AMGEN1
ANTAROS MEDICAL AB1
ASCENION1
ASSOCIATION OF EUROPEAN SCIENCE & TECHNOLOGY TRANSFER PROFESSIONALS1
ASTELLAS PHARMA EUROPE BV1
ASTRAZENECA1
AUDION THERAPEUTICS BV1
AZIENDA OSPEDALIERA PER L EMERGENZA CANNIZZARO1
Bangor University1
BAR ILAN UNIVERSITY1
BIOCYTEX1
BIONOTUS1
BOWEL RESEARCH UK1
BRAND NEW HEALTH NV1
BRISTOLMYERS SQUIBB COMPANY CORP1
CANCER INTELLIGENCE LIMITED1
CAREGIVERS ISRAEL1
CENTRE HOSPITALIER UNIVERSITAIRE DE MONTPELLIER1
CENTRE HOSPITALIER UNIVERSITAIRE DE ROUEN1
CENTRE HOSPITALIER UNIVERSITAIRE DE TOULOUSE1
CENTRE HOSPITALIER UNIVERSITAIRE VAUDOIS1
CIAOTECH1
CLALIT HEALTH SERVICES1
CLINQUEST SERVICES BV1
COMMISSARIAT A L'ENERGIE ATOMIQUE1
CONSEQUENTIAL ROBOTICS LIMITED1
CONSIGLIO NAZIONALE DELLE RICERCHE1
CONSORZIO PER VALUTAZIONI BIOLOGICHE E FARMACOLOGICHE1
CROSS TECHNOLOGY SOLUTIONS AB1
CYTOMINE1
CYTOMINE CORPORATION1
DECIPHEX LIMITED1
DEUTSCHE KREBSGESELLSCHAFT EV1
DEUTSCHES KREBSFORSCHUNGSZENTRUM HEIDELBERG1
DIGITAL PATHOLOGY ASSOCIATION INC1
DIN DEUTSCHES INSTITUT FUER NORMUNG EV1
DRESDEN UNIVERSITY OF TECHNOLOGY1
DUALTPHARMA1
EATRIS ERIC1
ECRIN EUROPEAN CLINICAL RESEARCH INFRASTRUCTURE NETWORK1
EHV ISRAEL LIMITED PARTNERSHIP1
EINDHOVEN UNIVERSITY OF TECHNOLOGY1
ELEVATE BV1

Constancy:

Total number of partners: 345
Partner loyalty:
Frequent Partner: (> 2 projects): 58
Rare Partner: 287
Frequent / Rare Partner Ratio: 0.2

Project overview:

Start dateProjectacronymrolefundingpartners
2022-09-01Providing cutting edge cancer research services across Europe canSERVparticipant14.866.44118
2021-10-01Optimal treatment for patients with solid tumours in Europe through Artificial intelligence OPTIMAparticipant10.459.99739
2021-02-01Central Repository for Digital Pathology BIGPICTUREparticipant32.319.82551
2021-01-01International consortium for integrative genomics prediction INTERVENEparticipant10.434.94018
2020-09-01Anchored Muscle cELls for IncontinencE AMELIEparticipant9.526.09713
2019-10-01Immune-Image: Specific Imaging of Immune Cell Dynamics Using Novel Tracer Strategies Immune-Imageparticipant15.000.00023
2019-04-01Building an ecosystem for better monitoring and communicating of medication safety in pregnancy and breastfeeding: validated and regulatory endorsed workflows for fast, optimised evidence generation ConcePTIONparticipant15.299.99153
2019-04-01Thrombo-inflammation in cardiovascular disease TICARDIOparticipant3.944.03810
2018-09-01The European Training Network on Informal Care ENTWINEparticipant4.091.89427
2018-05-01Prostate Cancer DIagnOsis and TreatmeNt Enhancement through the Power of Big Data in EuRope PIONEERparticipant6.000.00034
2018-01-01European Liquid Biopsies Academy - Towards widespread clinical application of blood- based diagnostic tools ELBAparticipant3.727.72321
2017-12-01A Next Generation Immunotherapy for Human Papilloma Virus induced Cervical Cancer IMMUNISAparticipant6.000.0006
2017-10-01A new era in personalised medicine: Radiomics as decision support tool for diagnostics and theragnostics in oncology PREDICTparticipant3.860.06018
2017-01-01The EU-HEALTH INNOVATION MARKETPLACE, the valorization platform for (FP7 Health and H2020 SC1) research results UTILEcoordinator1.999.62412
2016-05-01Scaling-up biodegradable nanomedicines for multimodal for multimodal precision cancer immunotherapy PRECIOUSparticipant8.291.21811
2015-05-01REgeneration of inner ear hair cells with GAmma-secretase INhibitors to regain hearing in patients with sensorineural hearing loss REGAINparticipant5.834.3407